home > drugs a-z list > amytal sodium (amobarbital sodium injection) drug center > amytal sodium (amobarbital sodium injection) drug

Recommended Topic Related To:

Amytal Sodium

What is insomnia?

Insomnia is defined as difficulty initiating or maintaining sleep, or both, despite adequate opportunity and time to sleep, leading to impaired daytime functioning. Insomnia may be due to poor quality or quantity of sleep.

Insomnia is very common and occurs in 30% to 50% of the general population. Approximately 10% of the population may suffer from chronic (long-standing) insomnia.

Insomnia affects people of all ages including children, although it is more common in adults and its frequency increases with age. In general, women are affected more frequently than men.

Insomnia may be divided into three classes based on the duration of symptoms.

  • Insomnia lasting one week or less may be termed transient insomnia;
  • short-term insomnia lasts more than one week but resolves in less than three weeks; and
  • long-term or chronic insomnia lasts more than three we...

Amytal Sodium

font size

AMYTAL® SODIUM
(amobarbital sodium) for Injection, USP

CAUTION: These products are to be used under the direction of a physician

The intravenous administration of Amytal® Sodium (Amobarbital Sodium for Injection, USP) carries with it the potential dangers inherent in the intravenous use of any potent hypnotic.

DRUG DESCRIPTION

The barbiturates are nonselective central nervous system (CNS) depressants that are primarily used as sedative hypnotics. In subhypnotic doses, they are also used as anticonvulsants. The barbiturates and their sodium salts are subject to control under the Federal Controlled Substances Act.

Amobarbital sodium is a white, friable, granular powder that is odorless, has a bitter taste, and is hygroscopic. It is very soluble in water soluble in alcohol, and practically insoluble in ether and chloroform. Amobarbital sodium is sodium 5-ethyl-5-isopentylbarbiturate and has the empirical formula C11H17N2Na03. Its molecular weight is 248.26. It has the following structural formula:

AMYTAL® SODIUM (Amobarbital sodium) structural formula illustration

Amobarbital sodium is a substituted pyrimidine derivative in which the basic structure is barbituric acid, a substance that has no CNS activity.

Vials of amobarbital sodium are for parenteral administration. The vials contain 500 mg (2 mmol) amobarbital sodium as a sterile lyophilized powder.

Last reviewed on RxList: 8/21/2009
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Sleep Disorders

Get tips for better sleep.